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ABSTRACT 
During pregnancy several drugs are having contraindication, hence their use is less and dangerous to mother along with fetus .Drugs 
play an important role in improving the health and promoting well-being. However to produce desired effect, they have to be safe, 
efficacious and have to be used rationally. During pregnancy medication is less preferred but in some times cannot be escaped to 
treat the ailments in mother. Avoiding medications may be desirable, it is often not possible and may be dangerous because some 
women enter pregnancy medical conditions that require continuous and episodic treatment (e.g. asthma, hypertension, epilepsy). So 
here we discussed the medication that can be used safely during pregnancy along with unsafe and highly contraindicated for both 
mother and fetus. Certain drugs given during pregnancy may prove harmful to unborn child is one of the classical problem in the 
medical treatment. The main purpose of this review is to prepare a list of safe medications which can be taken during pregnancy 
with unsafe and highly contraindicated drugs. And also a quick reference for health care professionals. 
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INTRODUCTION 
Pregnancy occurs when sperm meets an egg. Pregnancy is 
a period in which a fetus is developed into a women’s 
womb it contains one or more than one fetus 1. It is known 
as gestation period in the blood (or) urine pregnancy is 
confirmed symptoms of early pregnancy are-nausea, 
vomiting, mood swing, missed period, tender breast [1]. It 
contains three trimesters, first trimester from 1-12 weeks, 
in this stage conceiving takes place and also miscarriage. 
Second trimester from 13-28 weeks, in this stage fetus 
movement can be felt. Third trimester from 29-40 weeks, 
in this sage parental care is very essential 2. It has been 
reported that 8% of pregnant women need drug due to 
various chronic diseases and pregnancy related problems 3. 
About 59% of pregnant women are needed a medication 
other than a vitamin or mineral supplements 4. About 13% 
of pregnant women’s are taking dietary herbal 
supplements. More than 90% of pregnant women take 
prescription or nonprescription drugs or use social drugs 
such as tobacco or alcohol or illicit drugs at sometime 
during pregnancy [4]. Pregnant women are normally 
excluded from clinical trials and results from animal 
studies need not apply to human population 5. Hence 
providing treatment to pregnant women is a problem. Fear 
of causing fetal harm and death by a given drug in 
pregnancy has raised many challenges to clinical research 
about the safety use of drugs in pregnancy 5. Medication 
safety information in pregnancy is usually obtained from 
case reports, epidemiological studies and animal studies; 
all of which have some limitations that make determining 
risks of a drug use during pregnancy difficult 6. The use 
medications in pregnancy should be evaluated by the 
benefits and risks to the mother and fetus 7. Upon 
evaluation, some medications may be used sparingly 
during some trimesters contraindicated in others. All 
efforts should be made to optimize the risk-benefit ratio. 
It’s very important for the pregnant mothers to follow up of 
do’s and don’ts during the gestation period 7. The most 
important thing is the medication containing the mixture of 
chemicals, when interact together may cause the 
teratogenic effect to the baby 8. So it is very important for 
the health care professionals and pregnant woman to know 
which drugs can be take and which should not take during 
this period [8]. 
Principles of therapy in pregnancy: 9  
Prescribe drugs only when clearly indicated, through 
weighing benefits to mother against the risks to the fetus, 
based on the stage of pregnancy and drug information the 
drug should be selected, give the drug wih low effective 
doses and for the shortest effective time, an older and safe 
drug is preferred over a newer drug during first trimester, 
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provide counseling to pregnant women about the use of 
immunizations during pregnancy, should be avoided Live 
vaccines-possible harmful effects to fetus. (measles, 
mumps, polio, rubella). Toxoids (diphtheria, tetanus) and 
inactive virus vaccines ( influenza, rabies, hepatitis B ) are 
considered safe for use, Who are attacked by hepatitis B, 
rabies, tetanus, or varicella, hyper immune globulins 
(IGIVs) can be given to pregnant women, IV administration 
of hyper immune globulins reduce the risk of infection.[19] 
Principles of therapy in lactation: 10, 11 
Give drugs only when needed, avoid taking the 
contraindicated drugs or stop breast feeding, drugs taken 
by the systemic route can reach the infant in breast milk, 
lowest effective doses and for the shortest effective time 
should be prescribed, Stopping the breast feeding during 
maternal drug therapy is not recommended unless 
necessary, Women with HIV infection should not breast 
feed. Transmitted to the nursing infant, in some cases, 
mother may discard milk while receiving therapeutic 
drugs, to maintain lactation. 
Physiological changes: 12  
Weight increases and changes body shape (due to 
increases in breast tissue, blood volume in the extra 
vascular and extra cellular fluid), the average weight gain 
in pregnancy is 12.5 Kg. During normal pregnancy 1 Kg 
weight due to protein,13 The rate of albumin production 
increased but, plasma albumin levels are decreased( due to 
increased plasma volume), fibrinogen levels are increased 
and total body fat also increased. The ratio of LDL and HDL 
increases in pregnancy. 14 Renal blood flow increased and 
glomerular filtration rate secondary to increased to cardiac 
output. 
Pharmacokinetic changes: 15, 16  
The  drug effect can be changed by the changes 
pharmacokinetic  in pregnancy, hydrophilic drugs are more 
diluted and distributed In non pregnant women than 
pregnant women, Increased dose may require, 
Hydrophobic are more soluble in pregnant women, The 
free drug have therapeutic or adverse effects on the mother 
and for placental transfer to the fetus, excretion of drugs 
increased by kidneys, mainly which are excreted primarily 
unchanged in the urine (digoxin, lithium), In the pregnancy, 
the increased size of uterus decreased renal blood flow in 
supine position, This results in decreased excretion and 
prolonged effects of renally excreted drugs. 
Drug effects on the fetus: 17, 18, 19, 20 
The rate transfer drug depends on the chemical properties 
of drug such as protein binding, pH difference, lipid 
solubility and molecular weight of drug, only free unbound 
drug crosses the placenta, during pregnancy maternal 
albumin level are decreases while fetal albumin increases. 
As a result concentration of free drug increases which cross 
the placenta to reach the fetus, Fetal pH is slightly more 
acidic than maternal pH and so weak bases are more likely 
crossed the placenta, Lipid soluble drugs can easily diffuse 
across the placenta, Drug with low molecular weight (<500 
g/mol )diffuse freely across the placenta, Drugs with low 
molecular weight ( 500-1000 g/mol ) cross the placenta les 
easily, Drugs with high molecular weight (>1000 g/mol )do 
no cross he placenta, Trans placental transfer drugs 
increase in the third trimester due to increased maternal 
and placental blood flow, decreased thickness and 
increased surface of placenta, During first trimester, drug 
teratogenicity most likely occurs, when fetal organs are 
formed, During the second and third trimesters, drug 
adverse effects are: growth retardation, respiratory 
problems, infection, or bleeding. 
Drug categories in pregnancy:  
Drugs are teratogenic only at specific times during 
embryogenesis. Teratogenicity is a condition when any 
drug of chemical substance which produce deviations or 
abnormalities in the development of embryo. Therefore to 
avoid such problems it is very important to know which 
drugs should be prescribed during pregnancy 21. Food and 
drug administration (1979) of America enforce the rule for 
the categorization of the drug that is contraindicated 
during pregnancy so a classification has been carried out as 
following. 
The FDA has categorized the potential teratogenic risk of m
edications by an A, B, C, D, X system 22, 23, and 24.     
Category A: Controlled  studies  in  women  have  failed  to  
demonstrate  a  risk  to  the  fetus  in the first trimester 
and there is no evidence of risk in later trimesters. The pos
sibility of fetal harm appears remote. Medications in this cl
ass are considered safe to use in pregnancy. Examples of m
edications in this class are vitamins and levothyroxine.     
Category B: Either animal reproduction studies have 
not demonstrated a fetal risk but there are no controlled 
studies in pregnant women, or animal studies have 
demonstrated risk to the fetus that was not confirmed in 
controlled studies in pregnant women in the first trimester 
and there is no evidence of a risk in later trimesters. 
Medications in this class are generally considered safe. 
Examples of medications in this class are acetaminophen 
and amoxicillin.    
 
Category C: Studies in animals have revealed adverse effec
ts on the fetus and there are no controlled studies in wome
n, or studies in women and animals are not available. Drugs
 from this class can be given to pregnant women if the bene
fit to the mother outweighs the risk to the fetus. Examples 
of medications in this class are diltiazem and spironolacton
e.    
Category D: Evidence of human fetal risk has been docume
nted, but the benefits to the mother may be acceptable des
pite the risk to the fetus. Drugs in this class may be used in 
pregnancy if the benefits to themother outweigh the risk to 
the fetus (i.e. a life threatening situation or a serious diseas
e for which safermedication cannot be used or are not effic
acious). Examples of medications in this class are phenytoi
n and valproic acid.     
Category X: 
Studies in animals or humans have demonstrated teratogen
ic effects.  The risk to the fetus clearly outweighs any 
potential benefit to the mother. Drugs in this category are 
contraindicated in pregnancy.  Examples of medications in 
this class are thalidomide and warfarin. 
Command problems in pregnancy: 25, 26 Anemia, 
Constipation, Gastro esophageal reflux, Gestational 
diabetes, Nausea and vomiting, Hypertension. 
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Table 1: List of Antibiotics used in pregnancy: 27, 28, 29 
Generic (brand) Pregnancy 
Category 
Crosses 
placenta 
Reported adverse effects to mom or 
baby use in pregnancy 
Place in therapy 
Nitrofurantoin B Yes Fetus: Hemolytic anemia ---- 
Sulfamethoxazole  
/ trimethoprim  
  
C SMX: 
Unknown 
TMP: Yes 
Fetus: SMX: jaundice, hemolytic anemia, an
d possibly kernicterus  TMP: neural tube de
fects (NTD), oral clefts, cardiac defects,  
and urinary tract defects  
Not recommended in 
pregnancy 
Meronidazole 
(Flagyl) Topical:-
(metro gel) 
B Yes Fetus: Low birth weight babies, 
spontaneous abortions, and carcinogenic 
possibilities. Not  mutagenic or teratogenic 
 
Safe for use only in 
2nd and 3rd trimester 
Contraindicated in 1st 
trimester 
Tetracycline’s D Yes Fetus: Hypo spadia (1st trimester only), 
inguinal hernia, limb hypoplasia, teeth 
discoloration (2nd ,3rd) Cataracts, cleft 
palates, spine bifida, polydactyl, Maternal: 
liver toxicity, irreversible  shock 
No recommended in 
pregnancy 
Fluoroquinolones C Yes Erosion of weight bearing cartilage in rats 
and dogs, but no human reports 
Not recommended in 
pregnancy 
Macrolides Azithro, 
Erythro: B 
Claritro: C 
Yes Fetus: Cardiovascular abnormalities and 
cleft palate with clarithromcin 
 
Clindamycin   
B 
Yes Fetus: Increase in neonatal infection  and 
low birth weight  seen with vaginal 
preparation  
For BV as oral 
alternative, but not 
the topical Group B 
strep. disease in 
patients  with 
penicillin allergy 
Cephalosporin’s B Yes None reported Generally  considered  
safe in pregnancy  
unless penicillin 
allergic 
Penicillin’s +/-Beta-
lactamase inhibitor 
B Yes None reported Safest class of abx in 
pregnancy if not 
allergic for syphilis 
Amino glycosides 
(Amikacin, 
Gentamycin and 
Tobramycin) 
D Yes Fetus:  ototoxicity/ deafness 
Neuromuscular weakness, respiratory 
depression with concomitant gentamicin 
and Magnesium sulfate 
Do not use in 
pregnancy not unless 
the benefit out 
weight the risk to the 
fetus. 
 
Carbapenems: 30 Category B/C/B in pregnancy, likely 
cross the placenta, Very little human data 
Lactation: Excreted into breast milk in low amount, 
Unknown effects but likely low clinical significance 
Linezolid: Pregnancy Category C, No human data available 
Lactation: Unknown, myelo suppression in animals 
Chloramphenicol: Risk during pregnancy It is an 
antibiotic which is useful in serious infections such as 
typhoid fever. Not have any adverse effect but can cause 
‘grey baby syndrome’ and reversible bone marrow when it 
is given just before the delivery. 
Anti tubercular Agent: 31 
Streptomycin: Anti tubercular drug. It causes a minor 
effect to the fetus after crossing the placenta. It is mainly 
given to whom are resistant to rifampicin. 
Miscellaneous: Tetanus injection:  Injectable 
preparation is administered during second and third 
trimester of pregnancy to prevent tetanus 31.   
Probenecid: It is administered along with the penicillin 
and it is safe to be used during pregnancy.   
Calcium and Vitamin-D: These can    be    safely    given    
in    the    deficiency    states    and    in    accurate   doses. 
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Table 2: List of Anti epileptic drugs 32, 33, 34, 35 
Generic (brand) Pregnancy 
Category 
Crosses 
placenta 
Reported adverse effects to 
mom or baby use in pregnancy 
Place in therapy 
Carbamazepine  
(Tegretol)  
D Yes: levels 50‐8
0%  
of maternal, hig
hest  
in fetal liver an
d  kidneys  
Fetus: dysmorphic facial feature, 
cranial defects, cardiac defects, s
pina bifuda, fingernail  
hypoplasia, developmental delay,
mild mental retardation, neural t
ube defect 
Compatible –
Maternal Benefit >> Embryo/Fet
al Risk   If drug is required durin
g pregnancy it should not be with
held because the benefits ofpreve
nting seizures outweigh potential
 fetal hard. 
Ethosuximide 
(Zarontin) 
C Unknown Fetus: spontaneous hemorrhage, 
patent ductus arteriosus, cleft lip
/palate, mongoloid facies, short n
eck, altered palmar crease and ac
cessory nipple, hydrocephalu 
Limited human data. Probably co
mpatible.  Succinamide anticonv
ulsants: DOC for tx of  
petit mal epilepsy in 1st  
Trimester. 
Felbamate 
(Felbatol ) 
C Unknown Fetus: mental retardation. 
Maternal: aplastic  
anemia, acute liver failure 
Limited Human Data – 
Animal Data Suggest Moderate Ri
sk. Drug crosses placenta in anim
als, not yet described in humans. 
But should occur because 
of LMW  
Phenytoin 
(Dilatin) 
D 
Dose 
related 
teratogenic 
effect 
Unknown Fetus: congenital abnormalities, 
hemorrhage at  birth, 
neurodevelopment 
abnormalities 
Maternal: folic acid deficiency 
Compatible –
Maternal Benefit >>  
Embryo/Fetal Risk 
Significant Risks: major/minor c
ongenital  abnormalities, 
hemorrhage at birth,  
neurodevelopment  
Maintain lowest level required to
 prevent seizures in order to less
en risk of fetal  anomalies 
Fosphenatyoin 
(Cerebyx) 
D Unknown Fetus: congenital malformations, 
orofacial clefts, cardiac defects, m
inor anomalies, mental 
deficiency  
Maternal: An increase in seizure f
requency may occur during preg
nancy because of altered  
phenytoin pharmacokinetics 
Benefits from use in pregnant wo
men may be  acceptable 
despite the risk (e.g., if the drug i
s needed in a life‐threatening situ
ation or for a  serious 
disease for which safer drugs  
cannot be used or are ineffective) 
Gabapentin 
(Neurontin) 
C Unknown Limited human data does not 
allow an assessment as to the 
safety of gabapentin 
Limited Evidence: If required, be
nefits appear >  fetal risk 
Lomotrigine 
(Lamictal) 
C Yes Fetus: frequency of major defects
among 1st trimester 
monotherapy exposure was 2.9% 
(12  of 414)  
 Human data Suggest Low Risk; 
Adjust dose maintain clinical  
respons  
Levitiracetam(ke
ppra) 
C Unknown Risk to human fetus/embryo unk
nown 
Risk to human embryo/fetus is u
nknown 
Oxcarbamazepin
e (Trileptal) 
C Yes Fetus: no major congenital malfo
rmations  reported, mild facial 
defects observed in one  cas 
No epoxide metabolites: lower  
risk of teratogenicity compared  
to other agents,  Supplement  
with folic acid  
Phenobarbital 
(Luminal 
sodium) 
D Yes Fetus: congenital defects, 
hemorrhage at birth,  addiction, 
AE of neurobehavioral 
development   
Maternal: Benefit > Risk  
Benefits >Risk during at lowest  
effective level  
Pregablin 
(Lyrica) 
C Unknown Fetus: congenital defects, 
hemorrhage at birth,  addiction, 
AE of neurobehavioral 
development    
Maternal: Benefit > Risk 
  
Use only if maternal benefit>fetal
 risk 
Tiagabine 
(Gabitril) 
C Unknown Fetus: one incidence with unspec
ified  malformations, otherwise 
unknown  
Safest course: Avoid in 1st 
trimester; later  
trimesters unknown 
Primidone 
(Mysoline) 
D Unknown Newborn: neurologic 
manifestations 
If benefits > risks (e.g., drug  
needed in life‐ 
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Table 3: List of Diabetes mellitus 36 
generic 
(brand) 
class pregnancy 
category 
crosses 
placenta 
reported adverse effects 
to mom or baby from use 
in pregnancy 
place in therapy 
Glyburide (Giabeta, 
Micronase, 
Glynase) 
Sulfonylurea C Yes Possible ear defects in 1st 
trimester,  fetal 
hypoglycemia 
Insulin is recommended 
first line  by the ADA; 
ACOG recommends  
use of this agent in 
D2 or GDM   
Glipizide 
(Glucorol) 
Sulfonylurea C Yes Possible ear defects in 1st t
rimester, no  teratogenicity 
in animal studies 
Not recommended; limit
ed  human data  
Glimipiride 
(Amaryl) 
Sulfonylurea C Unknown Skeletal malformation in hi
gh doses 
Not recommended; No  
human  data  
Metformin 
(Glucophage,Forta
met,Glumeza) 
Biguanide B Unknown Neural tube defects in anim
als at high doses. 
Few abnormalities in huma
ns at  normal doses and 
likely due to poor BG  
control 
Insulin is recommended 
first line  by the ADA; 
ACOG recommends  
use of this agent in D2 or
 GDM 
Sitagliptin 
(Januvia) 
Dipeptidyl 
peptidase IV 
inhibitor 
B Unknown No good studies in humans;
 animal  studies show no 
defects/complication at  
high dose 
Possible; No human data  
Pioglitazone 
(Actos) 
TZD C Unknown Developmental delay, decr
eased fetal  weight in 
animals 
Not recommended  
Rosiglitazone 
(Avandia) 
TZD C Yes Fetal death/retardation wa
s seen in  animal studies 
Not recommended  
Exenatide 
(Byetta) 
Incretin 
mimetic 
C Unknown Decreased fetal growth, ske
letal malformations in ani
mal studies 
Not recommended  
Pramlintide 
(Symlin) 
Amylino 
mimetic 
C Unknown Animals: neural tube defect
s, cleft  palate at high doses 
Not recommended  
Regular insulin Short acting B NO None reported Drug of choice  
(overactivity /tumor); mechanis
m for hemorrhagic effects is due 
to suppression of VitK‐dependen
t clotting factors, recommend  
administration of VitK to infant i
mmediately  after birth 
threatening situation or serious  
disease with no  safer drug) 
Topiramate 
(Topamax) 
C Yes Hypospadias in males (relationsh
ip not established); Data too limit
ed to assess  embryo/fetus risk 
Avoid if possible in 1st trimester 
Valproic 
acid(Depakene) 
D Yes Fetus: neural tube defects, minor 
facial defects, defects of the head,
 face, digits, urogenital tract, men
tal and physical growth. 
Benefits > Risks (e.g., drug neede
d in life‐ threatening situation 
or serious disease with no  safer 
drug)  
Zonisamide 
(Zonegran) 
C Unknown Congenital anomalies possible Avoid if possible in 1st trimester 
Trimithadione D Unknown Fetus: mental retardation, cranio
facial defects,  genitourinary 
defects, malformed hands,  
clubfoot  
Contraindicated in 1st trimester 
Clonazepam 
(klonopin) 
D Unknown Human data suggest low risk; fet
al and neonatal  
toxicity has been reported 
Safest course is to avoid during  
the 1st trimester; however, 
if indicated, it should not  be 
withheld because of pregnancy 
Lorazepam 
(Ativan) 
D Yes Fetus: high IV doses may cause “f
loppy infant”  syndrome, higher 
incidence of respiratory  distress 
Benefits > Risks (e.g., drug neede
d in life‐ threatening situation 
or serious disease with no  
safer drug) 
Carbamazepine(
Tegretol) 
D Yes Fetus:minor craniofacial defects, 
fingernail  hypoplasia, 
developmental delay, mild 
mental  retardation  
If required, Benefits > risks 
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(HumulinR,Novolin 
R) 
insulin 
Lispro insulin 
(Humalog) 
Rapid acting 
insulin 
B NO Case reports: sudden neon
atal death,  growth 
retardation; controlled stu
dies:  as efficacious as 
regular insulin  
Recommended 
Glulisine insulin 
(Apidra) 
Rapid acting 
insulin 
C Unknown No available studies Not recommended unles
s  benefits > risks  
NPH insulin 
(Humulin N, 
Novolin N) 
Intermediae 
acting 
B NO None reported Recommended 
Glargine insulin 
(Lantus) 
Long acting C Unknown No available studies Not recommended  
unless  benefits > risks  
Detemir insulin 
(Levemir) 
Intermediae 
long acing 
C Unknown Visceral abnormalities  
were seen in  animals 
Not recommended  
 
Table 4: List of Analgesics Drugs 37, 38, 39, 40 
Generic 
(brand) 
Class Pregnancy 
category 
Crosses 
placenta 
Reported adverse effects to 
mom or baby from use in 
pregnancy 
Place in 
Therapy 
Aspirin 
(Bufferin, 
Ecotrin) 
NSAID C Yes Fetal: increased perinatal  
mortaility,  teratogenic 
 effects, pulmonary HTN,  
bleeding risk, premature ductus  
arteriosis closure 
Maternal: anemia, ante/post partu
m  hemorrhage,  prolonged labour 
Should not be used in  
pregnancy,  consider  
acetaminophen  
Ibuprofen 
(Advil, Midol) 
NSAID B D In 3rd 
trimester 
UNKNOWN Fetal: ductus arteriosis constrictio
n,Pulmonary HTN in 3rd trimester, 
Maternal:  prolonged  labor,  
spontaneous  abortion 
Should be avoided when 
possible and completely 
avoided during the 3rd  
trimester.  Consider acet
aminophen 
Naproxen 
(Aleve, 
Anaprox, 
Midol,Naprosy
n,Pamprin) 
NSAID B; D In 3rd 
trimester 
Yes Fetal: ductus arteriosis  
constriction,  intracranial  
hemorrhage, primary  
pulmonary HTN  
Should be avoided when 
possible and completely  
avoided during the 3rd  
trimester.   
Consider acetaminophen. 
Acetaminophe
n 
Analgesic 
antipyreti
c 
B Yes Fetal: overdose can lead to liver  
toxicity   Maternal:  
overdose can lead to liver  toxicity 
Drug of choice for analge
sia and  fever 
during pregnancy 
Butorphanol 
(Stadol) 
Narcotic 
analgesic 
C D if 
prolonged use 
Yes Fetal: sinusoidal fetal heart rate  
pattern,  addiction,  respiratory  
depression 
Maternal ‐ addiction 
Used for analgesia during
 labor  
Morphine ( 
Duramorph,Ka
dian. 
Narcotic 
analgesic 
C; D if 
prolonged use 
Yes Fetal: addiction, possible relation  
to  inguinal  hernia  and 
respiratory depression   
Maternal: addiction  
Should only be used  
when analgesia  
or anesthetic is clearly in
dicated 
Fentanyl 
(Actiq, 
Duragesic) 
Narcotic 
analgesic 
C; D if 
prolonged use 
Yes Fetal: respiratory depression,  
dependence  and  loss  of  fetal  
heart  rate  variability without 
hypoxia 
Only use when benefits > 
risks 
Hdromorphon
e (Dilaudid) 
Narcotic 
analgesic 
C D if 
prolonged use 
Yes Fetal: respiratory depression Only use when benefits > 
risks    
Manufacturer recommen
ded CI in  pregnancy 
Tramado 
(ultram) 
Narcotic 
analgesic 
C Yes Fetal: dose related fetal toxicity in  
animals, respiratory depression  
and  addiction 
Should be avoided until  
further evidence concern
ing the dose related  
fetal toxicity is available 
Ergotamine[Er
gomar] 
Sympatho
lytic 
X Yes Fetal: increase uterine tone leading
 to  fetal hypoxia, teratogenic and 
fetal  toxicity 
Do not use in pregnancy  
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Table 5: Cough and cold medications in pregnancy and lactation 41, 42, 43 
Drug or Drug Class Pregnancy Lactation 
Decongestants Pseudoephedrine, in the lowest dose and 
shortest duration possible is considered the 
decongestant of choice. However it may be 
prudent to avoid its use in the first trimester 
of pregnancy. Oxymetazoline and 
xylometazoline can be considered when used 
at appropriate doses for short durations. 
Systemic decongestants are best 
avoided if breast milk production is 
poor or marginal.  
Oxymetazoline and xylometazoline are 
considered drugs of choice 
Antihistamines The first generation antihistamines, 
especially chlorpheniramine, are preferred If 
not tolerated or effective, second generation 
agents such as loratadine can be 
recommended. 
Due to possible adverse effects on the 
infant from first generation 
antihistamines, second generation 
agents are preferred in lactating 
mothers. 
Antitussives-Codeine Codeine is best avoided during pregnancy. Avoid or limit codeine use in lactation 
due to risk of infant toxicity. 
Antitussives-
Dextromethorphan 
Dextromethorphan is the preferred 
antitussive in both pregnancy and lactation. 
Consider lack of evidence of efficacy. 
Dextromethorphan is the preferred 
antitussive in both pregnancy and 
lactation. Consider lack of evidence of 
efficacy. 
Expectorant Guaifenesin is considered safe in pregnancy 
and lactation. Consider lack of evidence of 
efficacy. 
Guaifenesin is considered safe in 
pregnancy and lactation. Consider lack 
of evidence of efficacy. 
Analgesics-Aceaminophen Acetaminophen is considered the 
analgesic/antipyretic of choice in both 
pregnancy and breastfeeding. 
Acetaminophen is considered the 
analgesic/antipyretic of choice in both 
pregnancy and breastfeeding. 
Analgesics-ASA and NSAIDS 
(naproxen and ibuprofen) 
ASA and NSAIDs are considered compatible 
with pregnancy in the first and second 
trimester, but should be avoided in the third 
trimester. 
 
Low-dose ASA is considered to pose lower 
risk during pregnancy and breastfeeding. 
Non-aspirin NSAIDs are generally 
considered compatible during 
breastfeeding and ibuprofen is the 
NSAID of choice due to greatest safety 
data. 
 Low-dose ASA is considered to pose 
lower risk during pregnancy and 
breastfeeding. 
Lozenges Medicated throat lozenges are considered 
safe in pregnancy and breastfeeding. 
Medicated throat lozenges are 
considered safe in pregnancy and 
breastfeeding. 
Herbs for Cough and Cold Echinacea and ginseng (all forms) should be 
avoided during pregnancy and 
breastfeeding.  
Echinacea and ginseng (all forms) 
should be avoided during pregnancy and 
breastfeeding.  
 
Table 6: List of Drugs during Immunizations 44 
generic 
(brand) 
Class pregnancy 
category 
crosses 
placenta 
reported adverse 
effects to mom or 
baby from use in 
pregnancy 
place in 
therapy 
Human 
papillomavirus 
(Gardasil) 
Inactivated 
vaccine 
B Unknown Currently under study Do not use during 
pregnancy 
Hepatitis B 
(Engerix-B, 
Recombvivax HB) 
Inactivated 
vaccine 
C Unknown No risk to the mom or 
baby have been  
reported  
The vaccine should 
be given pre or post 
exposure in women  
at risk for infection.  
Influenza 
(injection)(Afluria, 
Fluarix, 
Flilaval,Fluvirin, 
Fluzone) 
Inactivated 
vaccine 
C Unknown Studies of immunizati
on of over 2000  
women  showed  
no fetal  adverse  
effects  
associated with vaccin
ation  
 ACOG recommends 
 the vaccine be given 
to pregnant women  
in the 2nd and 3rd 
trimesters during flu 
season.  All at risk for 
pulmonary  
complications  
should be vaccinated, 
regardless of  
trimester  
MMR (M‐M‐R II)  Live vaccine C Unknown Fetal infection with liv
e attenuated  
virus may occur  
Do not use during pre
gnancy, Avoid  
pregnancy  for 12 
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weeks after injection  
Pneumococcal  
Vaccine  
(Pneumovax) 
Inactivated 
vaccine 
C Maternal Ab 
yes 
Risk to the fetus in the 
1st trimester is  
unknown.  
Use if indicated in hig
h risk patients   
Td (Decavac)  Toxoid C Unknown No evidence of teratog
enicity  
Use if indicated   
TdP (Adacel,  
Boostrix) 
Toxoid C Maternal Ab 
yes 
Antibodies may also in
terfere with the infant’
s immune response to 
infant doses of DTaP, s
o infant may not be pr
otected. 
Use if at high risk for 
pertussiss 
Varicella  
Vaccine   
Live vaccine C Unknown Fetal infection may  
occur  
Do not use during  
pregnancy 
 
Social drugs: In addition to counsel the pregnant women 
regarding use of various prescribed and non- prescribed 
medications during pregnancy. They should be informed 
about risk of using following substances during pregnancy 
45. 
Cigarette smoking: Maternal smoking is one of the few 
known preventable cause’s prenatal morbidity and 
mortality 46. The most consistent effect of smoking on the 
fetus during pregnancy is reduction in birth weight. Birth 
defects of heart, brain and face are also more common 
among babies of smokers. Risk of sudden infant death 
syndrome (SIDS), Mis-located placenta (placenta previa), 
premature detachment of placenta, premature rupture of 
the membranes, preterm labor, uterine infections, 
miscarriages, stillbirths, premature births are increased47. 
Changes in uterine and placental oxygenation may be the 
causes of infant death, pre-maturity or spontaneous 
abortions. Therefore all women’s should be informed of the 
risk of smoking on the fetus and encouraged to quit 
smoking during pregnancy 48. 
Alcohol: Fetal alcohol syndrome is one of the most serious 
consequences of drinking during pregnancy 49. Risk of 
miscarriage almost doubles for women who drink alcohol 
in any form during pregnancy and birth weight of babies is 
substantially below normal 50. This syndrome includes 
inadequate growth before or after birth, facial defects, a 
small head, mental retardation and abnormal behavioral 
development. 
Caffeine: Caffeine is found in various quantities in many 
beverages, analgesics, diet aids and stimulants; hence it is 
the most commonly ingested drug during pregnancy. 
Evidence suggests that consuming caffeine during 
pregnancy possess little or no risk to the fetus. Caffeine 
contained in coffee, tea, and some sodas and some drugs is 
a stimulant that readily crosses the placenta to the fetus 51. 
If taken in high dose it may stimulate the fetus increasing 
heart and breathing rate. Caffeine also may decrease blood 
flow across placenta and decreases the absorption of iron, 
increasing risk of anemia. 
CONCLUSION  
The safe and unsafe medications during pregnancy is a 
very important prospective of life as it carries the two lives 
conjoined for the certain period of time. During that time 
period both the mother and fetus should be safe, sound and 
grow healthily. This review summarizes the safe and 
unsafe list of drugs during pregnancy it is the responsibility 
of all clinicians including pharmacists to counsel patients 
with complete, accurate and current information on the 
risks and benefits of using medications during pregnancy. 
The first safe methods to refrain from such interaction 
during pregnancy are always consulting the medical 
practitioners and prescribe the drugs even of OTC category 
especially during the pregnancy as there are so many 
complications in it. It is the important that the benefits and 
risk of stopping treatment to be explained and informed 
properly. Drug may also be less effective during pregnancy 
because of pharmacokinetic changes such as increased 
metabolism. Doses of these drugs may need to be adjusting 
during pregnancy. Also when selecting drugs to be used in 
pregnancy effectively, drugs that have been in use for a 
long time are often preferable because fetal safety has been 
established even through newer alternatives may be 
available.
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